David Thacker

919 total citations · 1 hit paper
28 papers, 683 citations indexed

About

David Thacker is a scholar working on Pharmacology, Organic Chemistry and Pharmacology. According to data from OpenAlex, David Thacker has authored 28 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 7 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in David Thacker's work include Pharmacogenetics and Drug Metabolism (10 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Inflammatory mediators and NSAID effects (4 papers). David Thacker is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Inflammatory mediators and NSAID effects (4 papers). David Thacker collaborates with scholars based in United States, Canada and Japan. David Thacker's co-authors include David A. Flockhart, Linda E. Klumpers, Zeruesenay Desta, Brian Capon, Stephen Brimijoin, John J. Lima, Roseann S. Gammal, Teri E. Klein, James P. Franciosi and Sara L. Van Driest and has published in prestigious journals such as Journal of the American Chemical Society, Langmuir and Clinical Pharmacology & Therapeutics.

In The Last Decade

David Thacker

25 papers receiving 644 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

2020 194 citations John J. Lima, Cameron D. Thomas et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Thacker United States	10	278	163	119	110	106	28	683
Dong‐Ryul Sohn South Korea	15	380 1.4×	134 0.8×	224 1.9×	171 1.6×	181 1.7×	27	864
P.A. Soons Netherlands	16	261 0.9×	152 0.9×	187 1.6×	140 1.3×	129 1.2×	27	876
Yoji Tokuma Japan	16	214 0.8×	141 0.9×	175 1.5×	193 1.8×	69 0.7×	49	797
DG Waller United Kingdom	17	241 0.9×	137 0.8×	229 1.9×	79 0.7×	41 0.4×	28	920
Keith K. H. Chan United States	22	116 0.4×	220 1.3×	185 1.6×	247 2.2×	92 0.9×	63	1.2k
Barbara Schug Germany	16	112 0.4×	99 0.6×	73 0.6×	151 1.4×	110 1.0×	47	991
Michael S. Ching Australia	18	295 1.1×	134 0.8×	170 1.4×	146 1.3×	63 0.6×	48	893
Richard H. Reuning United States	15	107 0.4×	133 0.8×	136 1.1×	146 1.3×	51 0.5×	45	809
Achiel Van Peer Belgium	19	319 1.1×	215 1.3×	202 1.7×	208 1.9×	129 1.2×	43	1.2k
Alvin N. Kotake United States	16	259 0.9×	84 0.5×	98 0.8×	132 1.2×	57 0.5×	27	663

Countries citing papers authored by David Thacker

Since Specialization

Citations

This map shows the geographic impact of David Thacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Thacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Thacker more than expected).

Fields of papers citing papers by David Thacker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Thacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Thacker. The network helps show where David Thacker may publish in the future.

Co-authorship network of co-authors of David Thacker

This figure shows the co-authorship network connecting the top 25 collaborators of David Thacker. A scholar is included among the top collaborators of David Thacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Thacker. David Thacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arwood, Matthew L., et al.. (2025). Protein Levels of 16 Cytochrome P450s and 2 Carboxyl Esterases Using Absolute Quantitative Proteomics: CYP2C9 and CYP3A4 Are the Most Abundant Isoforms in Human Liver and Intestine, Respectively. Pharmaceuticals. 18(12). 1789–1789.

Thacker, David, et al.. (2024). Chronic Pain Management in a CYP2D6 Poor Metabolizer: A Case Report for Oxycodone. The Senior Care Pharmacist. 39(4). 137–142.

Thacker, David, et al.. (2022). Utilizing Pharmacogenomics Results to Determine Opioid Appropriateness and Improve Pain Management in a Patient with Osteoarthritis. Pharmacogenomics and Personalized Medicine. Volume 15. 943–950. 1 indexed citations

Thacker, David, et al.. (2021). Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report. Medicina. 57(9). 955–955. 3 indexed citations

Lima, John J., Cameron D. Thomas, Julia M. Barbarino, et al.. (2020). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. Clinical Pharmacology & Therapeutics. 109(6). 1417–1423. 194 indexed citations breakdown →

Thacker, David, Anil Modak, David A. Flockhart, & Zeruesenay Desta. (2012). Is (+)-[ ¹³ C]-pantoprazole better than (±)-[ ¹³ C]-pantoprazole for the breath test to evaluate CYP2C19 enzyme activity?. Journal of Breath Research. 7(1). 16001–16001. 9 indexed citations

Thacker, David, Anil Modak, Phuong D. Nguyen, David A. Flockhart, & Zeruesenay Desta. (2011). Stereoselective pharmacokinetics of stable isotope (+/−)‐[¹³C]‐pantoprazole: Implications for a rapid screening phenotype test of CYP2C19 activity. Chirality. 23(10). 904–909. 21 indexed citations

Thacker, David, et al.. (2000). In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms. Human & Experimental Toxicology. 19(3). 178–184. 37 indexed citations

Thacker, David, et al.. (1999). Metabolism of an anabolic androgenic steroid oxymetholone by human cytochrome P450s. Clinical Pharmacology & Therapeutics. 65(2). 136–136. 2 indexed citations

10.

Thacker, David, et al.. (1998). Method for the determination of 5,5-diphenylbarbituric acid and its separation from 1,3-dimethoxymethyl-5,5-diphenylbarbituric acid in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 710(1-2). 149–155. 1 indexed citations

11.

Trapnell, Carol Braun, Stephen Donahue, Jerry M. Collins, et al.. (1998). Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone*. Clinical Pharmacology & Therapeutics. 64(6). 597–602. 22 indexed citations

12.

Kerbusch, Thomas, Zeruesenay Desta, Nadia Soukhova, David Thacker, & David A. Flockhart. (1997). Sensitive assay for pimozide in human plasma using high-performance liquid chromatography with fluorescence detection: application to pharmacokinetic studies. Journal of Chromatography B Biomedical Sciences and Applications. 694(1). 163–168. 14 indexed citations

13.

Thacker, David, et al.. (1994). Application of the quartz crystal microbalance to characterize the interaction of solutes with modified interfaces. Langmuir. 10(6). 1642–1646. 13 indexed citations

14.

Renshaw, Harland W., et al.. (1976). Antibacterial Host Defense: In Vitro Interaction of Bacteria, Serum Factors, and Leukocytes from Precolostral Dairy Calves and Their Dams. American Journal of Veterinary Research. 37(11). 1267–1274. 1 indexed citations

15.

Thacker, David, et al.. (1976). Temperature‐dependence of rapid axonal transport in sympathetic nerves of the rabbit. Journal of Neurobiology. 7(4). 339–354. 38 indexed citations

16.

Albert, Adrien & David Thacker. (1972). v-Triazolo[4,5-d]pyrimidines (8-azapurines). Part XI. Preparation of 2-benzyl-v-triazolo[4,5-d]pyrimidine (8-benzyl-8-azapurine). Journal of the Chemical Society Perkin Transactions 1. 4. 468–468. 5 indexed citations

17.

Thacker, David & T. L. V. Ulbricht. (1968). Nucleosides. Part V. General Lewis acid catalysis of glycoside anomerisation and O→N-glycosyl rearrangement. Journal of the Chemical Society C Organic. 0(0). 333–337. 2 indexed citations

18.

Capon, Brian & David Thacker. (1967). The mechanism of the hydrolysis of glycofuranosides. Journal of the Chemical Society B Physical Organic. 185–185. 8 indexed citations

19.

Thacker, David & T. L. V. Ulbricht. (1967). General Lewis acid catalysis of glycoside anomerisation and O→N-glycosyl rearrangement. Chemical Communications (London). 0(3). 122–123. 2 indexed citations

20.

Capon, Brian & David Thacker. (1965). Nucleophilic Assistance in the Acid-Catalyzed Reactions of Acetals and Glycosides¹. Journal of the American Chemical Society. 87(18). 4199–4200. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact